CryoLife, Inc. (34)
Browse by Contract Category
Contracts
-
Change of Control Agreement, by and between the Company and D. Ashley Lee, dated Aug. 2, 2022
(Filed With SEC on November 4, 2022)
-
Form of Indemnification Agreement for Non-Employee Directors and Executive Officers
(Filed With SEC on November 4, 2022)
-
Artivion, Inc. Amended and Restated Employee Stock Purchase Plan
(Filed With SEC on May 20, 2022)
-
Plan of Conversion, effective January 1, 2022
(Filed With SEC on January 4, 2022)
-
Third Amendment to Lease Agreement between CryoLife, Inc. and The H.N. and Frances C. Berger Foundation, successor in interest to P&L Barrett, L.P., dated January 6, 2021
(Filed With SEC on April 30, 2021)
-
Change of Control Agreement, by and between the Company and Jean F. Holloway, dated Aug. 2, 2022
(Filed With SEC on November 4, 2022)
-
Change of Control Agreement, by and between the Company and John E. Davis, dated Aug. 2, 2022
(Filed With SEC on November 4, 2022)
-
Form of Artivion, Inc. Equity and Cash Incentive Plan Special PSU Award Agreement
(Filed With SEC on May 6, 2022)
-
Form of Artivion, Inc. Equity and Cash Incentive Plan Restricted Stock Unit Award Agreement
(Filed With SEC on May 6, 2022)
-
Form of Artivion, Inc. Equity and Cash Incentive Plan PSU Award Agreement
(Filed With SEC on May 6, 2022)
-
Form of Artivion, Inc. Equity and Cash Incentive Plan Option Award Agreement
(Filed With SEC on May 6, 2022)
-
Summary of 2021 Compensation Arrangements with Non-Employee Directors
(Filed With SEC on February 22, 2022)
-
Third Amendment to Credit and Guarantee Agreement between CryoLife, Inc. and Deutsche Bank AG New York Branch as administrative agent and collateral agent, dated June 2, 2021
(Filed With SEC on July 30, 2021)
-
Asset Purchase Agreement dated July 28, 2021, by among CryoLife, Inc., and Baxter Healthcare Company
(Filed With SEC on July 29, 2021)
-
First Amendment to Clinical Research Agreement, dated October 10, 2019, by and between CryoLife, Inc. and Duke University
(Filed With SEC on February 23, 2021)
-
Summary of 2020 Compensation Arrangements with Non-Employee Directors
(Filed With SEC on February 23, 2021)
-
First Amendment to Exclusive Distribution Agreement, by and between JOTEC GmbH, as distributor, and Endospan Ltd., as manufacturer, dated as of August 31, 2020
(Filed With SEC on February 23, 2021)
-
Lease Agreement between JOTEC GmbH and Frau Annika Sunnanvder for an objected located on the leased property at Lotzencker 25, dated October 28, 2020
(Filed With SEC on February 23, 2021)
-
Third Amendment to Lease Agreement between CryoLife, Inc. and The H.N. and Frances C. Berger Foundation, successor in interest to P&L Barrett, L.P., dated May 10, 2020
(Filed With SEC on February 23, 2021)
-
Securities Purchase Agreement, dated September 2, 2020, by and among CryoLife, Inc., Ascyrus Medical LLC, the securityholders of Ascyrus Medical LLC and the Securityholder...
(Filed With SEC on September 2, 2020)
-
Form of Salary Reduction Letter for the Companys Senior Management Operating Team, dated April 24, 2020
(Filed With SEC on July 31, 2020)
-
Second Amendment to Credit and Guaranty Agreement by and among CryoLife, Inc., CryoLife International, Inc., On-X Life Technologies Holdings, Inc., On-X Life Technologies, Inc.,...
(Filed With SEC on July 31, 2020)
-
Form of 2020 Non-Executive Director Restricted Stock Award Agreement
(Filed With SEC on July 31, 2020)
-
Purchase Agreement, dated as of June 18, 2020, by and between CryoLife, Inc. and Morgan Stanley & Co. LLC, as the initial purchaser
(Filed With SEC on June 23, 2020)
-
Indenture, dated as of June 23, 2020, by and between CryoLife, Inc. and U.S. Bank National Association, as trustee
(Filed With SEC on June 23, 2020)
-
Summary of 2019 Compensation Arrangements with Non-Employee Directors
(Filed With SEC on February 19, 2020)
-
Form of 2019 Long Term Incentive Program Performance Share Award Agreement pursuant to the CryoLife, Inc. Equity and Cash Incentive Plan
(Filed With SEC on February 19, 2020)
-
Form of 2019 Performance Share Award Agreement pursuant to the CryoLife, Inc. Equity and Cash Incentive Plan
(Filed With SEC on February 19, 2020)
-
Clinical Research Agreement, dated October 10, 2019, by and between CryoLife, Inc. and Duke University
(Filed With SEC on February 19, 2020)
-
Description of CryoLife, Inc.s Securities under Section 12 of the Exchange Act
(Filed With SEC on February 19, 2020)
-
Loan Agreement, dated September 11, 2019, by and between CryoLife, Inc., as lender, and Endospan Ltd., as borrower
(Filed With SEC on October 31, 2019)
-
Exclusive Distribution Agreement, dated September 11, 2019, by and between JOTEC GmbH, as distributor, and Endospan Ltd., as manufacturer
(Filed With SEC on October 31, 2019)
-
Summary of 2018 Compensation Arrangements with Non-Employee Directors
(Filed With SEC on February 26, 2019)
-
CryoLife, Inc. Equity and Cash Incentive Plan, as amended
(Filed With SEC on February 26, 2019)